Aaron Verty
Affiliations: | Physiology | Monash, Roodepoort, Gauteng, South Africa |
Google:
"Aaron Verty"Mean distance: 17.39 (cluster 40) | S | N | B | C | P |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Verty AN, Lockie SH, Stefanidis A, et al. (2013) Anti-obesity effects of the combined administration of CB1 receptor antagonist rimonabant and melanin-concentrating hormone antagonist SNAP-94847 in diet-induced obese mice. International Journal of Obesity (2005). 37: 279-87 |
| Verty AN, Evetts MJ, Crouch GJ, et al. (2011) The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 1349-58 |
| Verty AN, Allen AM, Oldfield BJ. (2010) The endogenous actions of hypothalamic peptides on brown adipose tissue thermogenesis in the rat. Endocrinology. 151: 4236-46 |
| Verty AN, Boon WM, Mallet PE, et al. (2009) Involvement of hypothalamic peptides in the anorectic action of the CB receptor antagonist rimonabant (SR 141716). The European Journal of Neuroscience. 29: 2207-16 |
| Stefanidis A, Verty AN, Allen AM, et al. (2009) The role of thermogenesis in antipsychotic drug-induced weight gain. Obesity (Silver Spring, Md.). 17: 16-24 |
| Verty AN, Allen AM, Oldfield BJ. (2009) The effects of rimonabant on brown adipose tissue in rat: implications for energy expenditure. Obesity (Silver Spring, Md.). 17: 254-61 |
| Verty A, Oldfield B. (2009) Evidence for a novel role for the CB2 receptors in the mediation of energy intake and expenditure Appetite. 52: 863 |
| Verty A, Oldfield B. (2007) The effect of the cannabinoid receptor antagonist, rimonabant (SR 141716) on energy expenditure. Appetite. 49: 337 |
| Verty AN, McGregor IS, Mallet PE. (2005) Paraventricular hypothalamic CB(1) cannabinoid receptors are involved in the feeding stimulatory effects of Delta(9)-tetrahydrocannabinol. Neuropharmacology. 49: 1101-9 |
| Singh ME, Verty AN, Price I, et al. (2004) Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716. Neuropharmacology. 47: 1157-69 |